The urology imaging systems market is projected to grow at a CAGR of 4% in the next five years. This growth is driven by the ...

Additionally, AI-powered imaging can play a pivotal role in active surveillance programs, where low-risk prostate cancer ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix”) today announces it has dosed the first patient in a Phase 3 clinical trial aimed at expanding the indications for Illuccix® and Gozellix® ...

Parkite Bernadette Greenwood recently earned an international award from the American Society of Radiologic Technologists.

MELBOURNE, Australia and INDIANAPOLIS, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces it has dosed the first patient in a Phase 3 ...

Combining MRI and PSMA-PET imaging has the potential to improve both ... However, this non-specific procedure can still miss significant prostate cancer, and can be painful and subject to ...

Imaging professionals who embrace lifelong learning and technological innovation are shaping the future of healthcare.

Nearly a year after Montell Jordan was diagnosed with Stage 1 prostate cancer and underwent a prostatectomy as treatment, the “This Is How We Do It” singer has revealed that follow-up scans detected ...

Screening with the prostate-specific antigen test can detect early-stage prostate cancer while it's still asymptomatic. But some men are diagnosed with prostate cancer only after symptoms appear. Marc ...

Here's why TFSA investors should gain exposure to undervalued growth stocks and generate game-changing wealth over the next ...

Clinically significant cancer was detected in 29.2 versus 29.6 percent of men with biparametric and multiparametric MRI.

Millions of men could benefit from a new, faster prostate cancer scan. The quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer in clinical trials as the current 30- to ...